IMMUNEERING CORPORATION
Ownership & governance
Executives 5Directors 6Avg age 59Avg tenure 7.9y
BZ
Benjamin Zeskind
Chief Executive Officer
Age 44Since 2008-01-31Profile →
+10
Executives5
BZ
Benjamin Zeskind→
Chief Executive Officer
Age 44Since 2008-01-31
MM
Mallory Morales→
Director of Finance/CFO
Age 42Since 2022-08-09
SN
Scott Nguyen→
Chief Tech/Sci/R&D Officer
—Since 2023-07-31
AG
Anastasia Gutierrez→
Chief Tech/Sci/R&D Officer
——
IM
Igor Matushansky→
Chief Tech/Sci/R&D Officer
Age 53Since 2025-03-19
Board of directors6
RC
Robert Carpenter→
Chairman
Age 81Since 2007-12-31
BZ
Benjamin Zeskind→
Director/Board Member
Age 44Since 2008-01-31
LK
Laurie Keating→
Director/Board Member
Age 72Since 2021-04-26
PF
Peter Feinberg→
Director/Board Member
Age 65Since 2020-12-31
DH
Diana Hausman→
Director/Board Member
Age 63Since 2022-01-17
TS
Thomas Schall→
Chairman
Age 66Since 2025-09-15
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Fidelity Management & Research Co. LLC | 14.99 % | 9,697,938 |
| HBM Partners AG (Investment Management) | 5.636 % | 3,646,304 |
| Benjamin Zeskind | 4.962 % | 3,210,179 |
| SANOFI | 4.187 % | 2,708,559 |
| Vanguard Capital Management LLC | 3.537 % | 2,288,341 |
Catalog · 2026-07-09
Registry officers11
| Name | Role | Since | Shares |
|---|---|---|---|
| Anastasia Gutierrez | Chief Tech/Sci/R&D Officer | — | - |
| Benjamin Zeskind | Chief Executive Officer | 2008-01-31 | - |
| Igor Matushansky | Chief Tech/Sci/R&D Officer | 2025-03-19 | - |
| Mallory Morales | Director of Finance/CFO | 2022-08-09 | - |
| Robert Carpenter | Chairman | 2007-12-31 | - |
| Scott Nguyen | Chief Tech/Sci/R&D Officer | 2023-07-31 | - |
| Thomas Schall | Chairman | 2025-09-15 | - |
| Benjamin Zeskind | Director/Board Member | 2008-01-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 17.17Range 12–30Analysts 6
12Mean 17.1730
- Strong buy 2
- Buy 5
Broker actions40 of 62
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Initiated | Buy | 14 | 2026-08-06 |
| Needham | Maintained | Buy | 18 | 2026-07-20 |
| Cantor Fitzgerald | Initiated | Overweight | — | 2026-07-08 |
| Chardan Capital | Maintained | Buy | 20 | 2026-05-19 |
| Needham | Reiterated | Buy | 11 | 2026-03-09 |
| Chardan Capital | Maintained | Buy | 20 | 2025-11-13 |
| Leerink Partners | Initiated | Outperform | 15 | 2025-10-31 |
| HC Wainwright & Co. | Reiterated | Buy | 11 | 2025-09-30 |
| Chardan Capital | Maintained | Buy | 20 | 2025-09-26 |
| Oppenheimer | Maintained | Outperform | 30 | 2025-09-25 |
| Needham | Maintained | Buy | 11 | 2025-09-15 |
| Needham | Reiterated | Buy | 8 | 2025-08-26 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.